Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus

Authors: Zhenhua Zhang, Yongqing Li, Shufang Xu, Fuyong Chen, Li Zhang, Beiyu Jiang, Xiaoling Chen

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Current vaccines to avian influenzae virus (AIV), a highly contagious disease of birds, need to be constantly updated due to the high level of variation in the target antigens. Therefore, a vaccine that could induce broad cross protection against AIV is required. The M2 membrane protein is structurally conserved amongst AIV subtypes but tends in induce a poor immune response, whereas C3d has been shown in many species to enhance immunogenicity. In this study, we investigated the potential of M2-avian C3d fusion proteins to provide effective immunity.

Results

We fused chicken complement C3d to sM2 (M2 protein with the transmembrane region deleted) of AIV and expressed four fusion proteins, GST (Glutathione S-transferase tagged proteins in pGEX expression vector) -C3d-sM2, GST-C3d-L2-sM2, GST-C3d-L1-C3d-sM2 and GST-C3d-L1-C3d-L2-sM2 were used to immunize mice. In addition, Specific pathogen free (SPF) chickens were inoculated with the plasmids pcDNA-sM2, pcDNA-C3d-L1-C3d-L2-sM2, GST-sM2 and GST-C3d-L1-C3d-L2-sM2. The immune response was monitored by an enzyme-linked immunosorbent assay (ELISA) for sM2 antibody, and all the test animals were challenged with A/chicken/Bei Jing/WD9/98 (H9N2) virus. Results revealed that the anti-sM2 antibody in mice and chickens vaccinated with these proteins was higher than the nonfused forms of sM2, the GST-C3d-L1-C3d-L2-sM2 groups have conferred the highest 30% and 20% protection ratio in mice and chickens respectively. In addition, the pcDNA-C3d-L1-C3d-L2-sM2 also enhances the antibody responses to sM2 compared to pcDNA-sM2 in chickens, and acquired 13.3% protection ratio.

Conclusion

These results indicated that chicken C3d enhanced the humoral immunity against AIV M2 protein either fused proteins expressed by the prokaryotic system or with the DNA vaccine. Nevertheless, in view of the poor protection ratio for these animals, we speculated that this is not a worthy developing of vaccine in these constructs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Nielsen CH, Fischer EM, Leslie RG: The role of complement in the acquired immune response. J Immunol 2000, 100: 4-12. 10.1046/j.1365-2567.2000.00009.xCrossRef Nielsen CH, Fischer EM, Leslie RG: The role of complement in the acquired immune response. J Immunol 2000, 100: 4-12. 10.1046/j.1365-2567.2000.00009.xCrossRef
2.
go back to reference Rus H, Cudrici C, Niculescu F: The role of the complement system in innate immunity. Immunol Res 2005, 33: 103-12. 10.1385/IR:33:2:103PubMedCrossRef Rus H, Cudrici C, Niculescu F: The role of the complement system in innate immunity. Immunol Res 2005, 33: 103-12. 10.1385/IR:33:2:103PubMedCrossRef
3.
go back to reference Thornton BP, Vetvicka V, Ross GD: Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994, 152: 1727-1737.PubMed Thornton BP, Vetvicka V, Ross GD: Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994, 152: 1727-1737.PubMed
4.
go back to reference Sahu A, Sunyer JO, Moore WT, Sarrias MR, Soulika AM, Lambris JD: Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol Res 1998, 17: 109-121. 10.1007/BF02786436PubMedCrossRef Sahu A, Sunyer JO, Moore WT, Sarrias MR, Soulika AM, Lambris JD: Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol Res 1998, 17: 109-121. 10.1007/BF02786436PubMedCrossRef
5.
go back to reference Sun-HL Jae UJ, Robert EM: Complementing viral infection: mechanisms for evading innate immunity. Trends in Microbiology 2003, 11: 449-452. 10.1016/j.tim.2003.08.004CrossRef Sun-HL Jae UJ, Robert EM: Complementing viral infection: mechanisms for evading innate immunity. Trends in Microbiology 2003, 11: 449-452. 10.1016/j.tim.2003.08.004CrossRef
6.
go back to reference Thornton BP, Vetvicka V, Ross GD: Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996, 104: 531-537. 10.1046/j.1365-2249.1996.57761.xPubMedPubMedCentralCrossRef Thornton BP, Vetvicka V, Ross GD: Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996, 104: 531-537. 10.1046/j.1365-2249.1996.57761.xPubMedPubMedCentralCrossRef
7.
go back to reference Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271: 348-350. 10.1126/science.271.5247.348PubMedCrossRef Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271: 348-350. 10.1126/science.271.5247.348PubMedCrossRef
8.
go back to reference Lou D, Kohler H: Enhanced molecular mimicry of CEA using photoaffinity cross-linked C3d peptide. Nature Biotechnology 1998, 16: 458-462. 10.1038/nbt0598-458PubMedCrossRef Lou D, Kohler H: Enhanced molecular mimicry of CEA using photoaffinity cross-linked C3d peptide. Nature Biotechnology 1998, 16: 458-462. 10.1038/nbt0598-458PubMedCrossRef
9.
go back to reference Ross TM, Xu Y, Bright RA, Robinson HL: C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunol 2000, 1: 127-131. 10.1038/77802CrossRef Ross TM, Xu Y, Bright RA, Robinson HL: C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nature Immunol 2000, 1: 127-131. 10.1038/77802CrossRef
10.
go back to reference Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G: Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine 1997, 15: 827-829. 10.1016/S0264-410X(96)00262-9PubMedCrossRef Anderson R, Gao XM, Papakonstantinopoulou A, Fairweather N, Roberts M, Dougan G: Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine 1997, 15: 827-829. 10.1016/S0264-410X(96)00262-9PubMedCrossRef
11.
go back to reference Bower JF, Sanders KL, Ross TM: C3d Enhances Immune Responses Using Low Doses of DNA Expressing the HIV-1 Envelope from Codon-Optimized Gene Sequences. Curr HIV Res 2005, 3: 191-198. 10.2174/1570162053506937PubMedPubMedCentralCrossRef Bower JF, Sanders KL, Ross TM: C3d Enhances Immune Responses Using Low Doses of DNA Expressing the HIV-1 Envelope from Codon-Optimized Gene Sequences. Curr HIV Res 2005, 3: 191-198. 10.2174/1570162053506937PubMedPubMedCentralCrossRef
12.
go back to reference Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL: Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120-C3d Fusion Proteins. AIDS Res Hum Retroviruses 2001, 617: 829-835. 10.1089/088922201750252025CrossRef Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL: Enhanced Avidity Maturation of Antibody to Human Immunodeficiency Virus Envelope: DNA Vaccination with gp120-C3d Fusion Proteins. AIDS Res Hum Retroviruses 2001, 617: 829-835. 10.1089/088922201750252025CrossRef
13.
go back to reference Wang L, Oriol Sunyer J, Bello LJ: Immunogenicity of a bovine viral diarrhea virus E2-C3d fusion protein containing a bovine homolog of C3d. Developmental and comparative immunology 2005, 29: 907-915. 10.1016/j.dci.2005.01.007PubMedCrossRef Wang L, Oriol Sunyer J, Bello LJ: Immunogenicity of a bovine viral diarrhea virus E2-C3d fusion protein containing a bovine homolog of C3d. Developmental and comparative immunology 2005, 29: 907-915. 10.1016/j.dci.2005.01.007PubMedCrossRef
14.
go back to reference Liu D, Niu ZX: Cloning of a gene fragment encoding chicken complement component C3d with expression and immunogenicity of Newcastle disease virus F gene-C3d fusion protein. Avian Pathol 2008, 37: 477-485. 10.1080/03079450802356920PubMedCrossRef Liu D, Niu ZX: Cloning of a gene fragment encoding chicken complement component C3d with expression and immunogenicity of Newcastle disease virus F gene-C3d fusion protein. Avian Pathol 2008, 37: 477-485. 10.1080/03079450802356920PubMedCrossRef
15.
go back to reference Logan GJ, Wang L, Zheng M, Coppel RL, Alexander IE: Antigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines in a transgene-dependent manner. Immunol Cell Biol 2010, 88: 228-32. 10.1038/icb.2009.92PubMedCrossRef Logan GJ, Wang L, Zheng M, Coppel RL, Alexander IE: Antigen fusion with C3d3 augments or inhibits humoral immunity to AAV genetic vaccines in a transgene-dependent manner. Immunol Cell Biol 2010, 88: 228-32. 10.1038/icb.2009.92PubMedCrossRef
16.
go back to reference Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ: Protection of mice against influenza A virus challenge by vaccination with baculovirus expressed M2 protein. Vaccine 1995, 13: 1399-1402. 10.1016/0264-410X(95)92777-YPubMedCrossRef Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ: Protection of mice against influenza A virus challenge by vaccination with baculovirus expressed M2 protein. Vaccine 1995, 13: 1399-1402. 10.1016/0264-410X(95)92777-YPubMedCrossRef
17.
go back to reference Frace AM, Klimov AI, Rowe T, Black RA, Katz JM: Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999, 17: 2237-2244. 10.1016/S0264-410X(99)00005-5PubMedCrossRef Frace AM, Klimov AI, Rowe T, Black RA, Katz JM: Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine 1999, 17: 2237-2244. 10.1016/S0264-410X(99)00005-5PubMedCrossRef
18.
go back to reference Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5: 1157-1163. 10.1038/13484PubMedCrossRef Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5: 1157-1163. 10.1038/13484PubMedCrossRef
19.
go back to reference Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, Zheng BJ, Zhou Y: An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J 2010, 18: 7-9. Zhao G, Lin Y, Du L, Guan J, Sun S, Sui H, Kou Z, Chan CC, Guo Y, Jiang S, Zheng BJ, Zhou Y: An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J 2010, 18: 7-9.
20.
go back to reference Rao SS, Kong WP, Wei CJ, Van Hoeven N, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ: Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS One 2010, 5: e9812. 10.1371/journal.pone.0009812PubMedPubMedCentralCrossRef Rao SS, Kong WP, Wei CJ, Van Hoeven N, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ: Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS One 2010, 5: e9812. 10.1371/journal.pone.0009812PubMedPubMedCentralCrossRef
21.
go back to reference Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos L Jr, Gerhard W: Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003, 21: 2616-2626. 10.1016/S0264-410X(03)00040-9PubMedCrossRef Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos L Jr, Gerhard W: Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Vaccine 2003, 21: 2616-2626. 10.1016/S0264-410X(03)00040-9PubMedCrossRef
22.
go back to reference Nauta AJ, Roos A, Daha MR: A regulatory role for complement in innate immunity and autoimmunity. Int Arch Allergy Immunol 2004, 134: 310-323. 10.1159/000079261PubMedCrossRef Nauta AJ, Roos A, Daha MR: A regulatory role for complement in innate immunity and autoimmunity. Int Arch Allergy Immunol 2004, 134: 310-323. 10.1159/000079261PubMedCrossRef
23.
go back to reference Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF: Cutting edge: C3d function as a molecular adjuvant in absence of CD21/35 expression. J Immunol 2004, 172: 5833-5839.PubMedCrossRef Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF: Cutting edge: C3d function as a molecular adjuvant in absence of CD21/35 expression. J Immunol 2004, 172: 5833-5839.PubMedCrossRef
24.
go back to reference Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256: 105-107. 10.1126/science.1373518PubMedCrossRef Carter RH, Fearon DT: CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 1992, 256: 105-107. 10.1126/science.1373518PubMedCrossRef
25.
go back to reference Hess MW, Schwendinger MG, Eskelinen EL, Pfaller K, Pavelka M, Dierich MP, Prodinger WM: Tracing uptake of C3dg-conjugated antigen in B cells via complement receptor type 2(CR2, CD21). Blood 2000, 95: 2617-2623.PubMed Hess MW, Schwendinger MG, Eskelinen EL, Pfaller K, Pavelka M, Dierich MP, Prodinger WM: Tracing uptake of C3dg-conjugated antigen in B cells via complement receptor type 2(CR2, CD21). Blood 2000, 95: 2617-2623.PubMed
26.
go back to reference Cherukuri A, Cheng PC, Pierce SK: The role of the CD19/CD21 complex in B cell processing and presentation of complement: Tagged antigen. J Immunol 2001, 167: 163-172.PubMedCrossRef Cherukuri A, Cheng PC, Pierce SK: The role of the CD19/CD21 complex in B cell processing and presentation of complement: Tagged antigen. J Immunol 2001, 167: 163-172.PubMedCrossRef
27.
go back to reference Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF: Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement. J Immunol 2005, 75: 8011-8023.CrossRef Lee Y, Haas KM, Gor DO, Ding X, Karp DR, Greenspan NS, Poe JC, Tedder TF: Complement Component C3d-Antigen Complexes Can Either Augment or Inhibit B Lymphocyte Activation and Humoral Immunity in Mice Depending on the Degree of CD21/CD19 Complex Engagement. J Immunol 2005, 75: 8011-8023.CrossRef
28.
go back to reference Green TD, Montefiori DC, Ross TM: Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 2003, 77: 2046-2055. 10.1128/JVI.77.3.2046-2055.2003PubMedPubMedCentralCrossRef Green TD, Montefiori DC, Ross TM: Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J Virol 2003, 77: 2046-2055. 10.1128/JVI.77.3.2046-2055.2003PubMedPubMedCentralCrossRef
29.
go back to reference Mitchell JA, Green TD, Bright RA, Ross TM: Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003, 21: 902-914. 10.1016/S0264-410X(02)00539-XPubMedCrossRef Mitchell JA, Green TD, Bright RA, Ross TM: Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 2003, 21: 902-914. 10.1016/S0264-410X(02)00539-XPubMedCrossRef
30.
go back to reference Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM: C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2002, 20: 242-248. 10.1016/S0264-410X(01)00266-3CrossRef Green TD, Newton BR, Rota PA, Xu Y, Robinson HL, Ross TM: C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 2002, 20: 242-248. 10.1016/S0264-410X(01)00266-3CrossRef
31.
go back to reference Henson SE, Smith D, Boackle SA, Holers VM, Karp DR: Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J Immunol Methods 2001, 258: 97-107. 10.1016/S0022-1759(01)00471-9PubMedCrossRef Henson SE, Smith D, Boackle SA, Holers VM, Karp DR: Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function. J Immunol Methods 2001, 258: 97-107. 10.1016/S0022-1759(01)00471-9PubMedCrossRef
32.
go back to reference Frinklln R, Ross TM: Mouse strain-dependent differences in enhancement of immune response by C3d. Vaccine 2004, 22: 1773-1778. 10.1016/j.vaccine.2003.10.050CrossRef Frinklln R, Ross TM: Mouse strain-dependent differences in enhancement of immune response by C3d. Vaccine 2004, 22: 1773-1778. 10.1016/j.vaccine.2003.10.050CrossRef
33.
go back to reference Suradhat S, Braun RP, Lewis PJ, Babiuk LA, Hurk S, Griebel PJ, Baca-Estrada ME: Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1glycoprotein D inhibits immune responses following DNA immunization. J Vet Immunol 2001, 83: 79-92. 10.1016/S0165-2427(01)00369-5CrossRef Suradhat S, Braun RP, Lewis PJ, Babiuk LA, Hurk S, Griebel PJ, Baca-Estrada ME: Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1glycoprotein D inhibits immune responses following DNA immunization. J Vet Immunol 2001, 83: 79-92. 10.1016/S0165-2427(01)00369-5CrossRef
34.
go back to reference Bower JF, Yang X, Sodroski J, Ross TM: Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated C3d. J virol 2004, 78: 4710-4719. 10.1128/JVI.78.9.4710-4719.2004PubMedPubMedCentralCrossRef Bower JF, Yang X, Sodroski J, Ross TM: Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated C3d. J virol 2004, 78: 4710-4719. 10.1128/JVI.78.9.4710-4719.2004PubMedPubMedCentralCrossRef
35.
go back to reference Green TD, Montefiori DC, Ross TM: Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d. J Virol 2003, 77: 2046-2055. 10.1128/JVI.77.3.2046-2055.2003PubMedPubMedCentralCrossRef Green TD, Montefiori DC, Ross TM: Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d. J Virol 2003, 77: 2046-2055. 10.1128/JVI.77.3.2046-2055.2003PubMedPubMedCentralCrossRef
36.
go back to reference Roberts T, Snow EC: Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J Immunol 1999, 162: 4377-4380.PubMed Roberts T, Snow EC: Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells. J Immunol 1999, 162: 4377-4380.PubMed
37.
go back to reference Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ: Mapping of the receptor (CR2) binding site and antigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci 1985, 82: 4235-4239. 10.1073/pnas.82.12.4235PubMedPubMedCentralCrossRef Lambris JD, Ganu VS, Hirani S, Müller-Eberhard HJ: Mapping of the receptor (CR2) binding site and antigenic site in the C3d domain of the third component of complement. Proc Natl Acad Sci 1985, 82: 4235-4239. 10.1073/pnas.82.12.4235PubMedPubMedCentralCrossRef
38.
go back to reference Hellwage J, Jokiranta TS, Friese MA, Wolk TU, Kampen E, Zipfel PF, Meri S: Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 2002, 169: 6935-6942.PubMedCrossRef Hellwage J, Jokiranta TS, Friese MA, Wolk TU, Kampen E, Zipfel PF, Meri S: Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 2002, 169: 6935-6942.PubMedCrossRef
39.
go back to reference Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S: Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gpl20 glycoprotein by codon optimization and C3d fusion in a mouse mode1. Vaccine 2004, 22: l764-1772. 10.1016/j.vaccine.2003.09.054CrossRef Liu F, Mboudjeka I, Shen S, Chou TH, Wang S, Ross TM, Lu S: Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gpl20 glycoprotein by codon optimization and C3d fusion in a mouse mode1. Vaccine 2004, 22: l764-1772. 10.1016/j.vaccine.2003.09.054CrossRef
40.
go back to reference Mitsuyoshi JK, Hu Y, Test ST: Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2005, 73: 7311-7316. 10.1128/IAI.73.11.7311-7316.2005PubMedPubMedCentralCrossRef Mitsuyoshi JK, Hu Y, Test ST: Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide. Infect Immun 2005, 73: 7311-7316. 10.1128/IAI.73.11.7311-7316.2005PubMedPubMedCentralCrossRef
41.
go back to reference Bower JF, Sanders KL, Ross TM: C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. Curr HIV Res 2005, 3: 191-198. 10.2174/1570162053506937PubMedPubMedCentralCrossRef Bower JF, Sanders KL, Ross TM: C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. Curr HIV Res 2005, 3: 191-198. 10.2174/1570162053506937PubMedPubMedCentralCrossRef
42.
go back to reference Zhang ZH, Zhou XM, Chen NH, Chen XL, Luo CB, Li YQ: Cloning and Structural Analysis of Chicken Complement Component C3d Gene. J Biotechnology Letter 2006, 17: 267-270. [In Chinese]. Zhang ZH, Zhou XM, Chen NH, Chen XL, Luo CB, Li YQ: Cloning and Structural Analysis of Chicken Complement Component C3d Gene. J Biotechnology Letter 2006, 17: 267-270. [In Chinese].
43.
go back to reference Li YQ, Yao SX, Wei L, Yang HC: Deletion of coding sequence of transmembrane domain of M2 protein of Avian Influenza virus. Chinese Journal of Veterinary Medicine 2004, 40: 6-9. [In Chinese]. Li YQ, Yao SX, Wei L, Yang HC: Deletion of coding sequence of transmembrane domain of M2 protein of Avian Influenza virus. Chinese Journal of Veterinary Medicine 2004, 40: 6-9. [In Chinese].
44.
go back to reference Li YQ, Yang J, Wei L, Yang HC: Expression of Avian Influenza Virus M2 Gene in E. coli and Analysis of its antigenicity. Acta Veterinaria et Zootechnica Sinica 2005, 36: 739-743. [In Chinese]. Li YQ, Yang J, Wei L, Yang HC: Expression of Avian Influenza Virus M2 Gene in E. coli and Analysis of its antigenicity. Acta Veterinaria et Zootechnica Sinica 2005, 36: 739-743. [In Chinese].
Metadata
Title
Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus
Authors
Zhenhua Zhang
Yongqing Li
Shufang Xu
Fuyong Chen
Li Zhang
Beiyu Jiang
Xiaoling Chen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-89

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue